NATCOPHARM

Natco Pharma Ltd. · ISIN INE987B01026 · Health Technology

Margin Trading Facility book for NATCOPHARM across NSE and BSE. Free to use — no signup, no paywall. All figures in ₹ crore, derived from NSE and BSE public disclosures.

Funded value
₹164 Cr
as of 23 Jul 2026
Rank in book
#229
368 days tracked
Share of book
0.11%
of the whole NSE + BSE book
Peak funded
₹260 Cr
on 27 Jan 2025
NSE
₹159 Cr
BSE
₹5 Cr
Largest single-day addition
+₹26 Cr
on 15 Oct 2025
Largest single-day unwind
−₹25 Cr
on 20 Nov 2025

NATCOPHARM — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole market book, and rank. Newest first.
DateCombinedDay ΔNSEBSE% of bookRank
23 Jul 2026₹164 Cr+₹2₹159₹50.11%229
22 Jul 2026₹162 Cr+₹2₹158₹50.11%231
21 Jul 2026₹160 Cr−₹2₹156₹40.11%233
20 Jul 2026₹162 Cr+₹4₹158₹40.11%229
17 Jul 2026₹159 Cr+₹2₹154₹40.11%236
16 Jul 2026₹157 Cr−₹0₹153₹40.11%237
15 Jul 2026₹157 Cr+₹1₹153₹40.11%232
14 Jul 2026₹156 Cr+₹0₹152₹40.11%234
13 Jul 2026₹155 Cr−₹0₹151₹40.11%234
10 Jul 2026₹156 Cr+₹0₹151₹40.11%231
09 Jul 2026₹155 Cr+₹1₹151₹40.11%234
08 Jul 2026₹154 Cr−₹1₹150₹40.11%234
07 Jul 2026₹155 Cr−₹16₹151₹40.11%233
06 Jul 2026₹170 Cr+₹1₹165₹50.12%210
03 Jul 2026₹170 Cr−₹1₹165₹50.12%213
02 Jul 2026₹170 Cr−₹2₹165₹50.12%216
01 Jul 2026₹172 Cr−₹4₹167₹50.12%215
30 Jun 2026₹176 Cr−₹8₹171₹50.12%206
29 Jun 2026₹184 Cr−₹9₹179₹50.13%189
25 Jun 2026₹193 Cr−₹5₹188₹50.14%173
24 Jun 2026₹198 Cr−₹3₹192₹60.14%169
23 Jun 2026₹201 Cr+₹3₹196₹60.14%165
22 Jun 2026₹198 Cr+₹1₹192₹60.14%166
19 Jun 2026₹197 Cr−₹1₹191₹60.14%166
18 Jun 2026₹199 Cr+₹3₹193₹60.15%159
17 Jun 2026₹196 Cr−₹0₹190₹60.15%165
16 Jun 2026₹196 Cr+₹2₹190₹60.15%164
15 Jun 2026₹195 Cr+₹10₹189₹60.15%165
12 Jun 2026₹185 Cr−₹2₹180₹50.14%175
11 Jun 2026₹187 Cr₹181₹60.14%173

IndiaMTF is an independent informational project. It is not a brokerage, is not affiliated with NSE, BSE or any SEBI-registered entity, and does not provide investment advice. Figures are derived from NSE and BSE public disclosures and may be revised or restated by the exchanges. Verify against the primary source before acting on anything here.